GPS2 and breast carcinoma: As Ubc13 overexpression was reported to promote breast cancer metastasis through aberrant activation of a TAK1/p38 MAPK kinase cascade (Wu et al., 2014), it is possible, for example, that loss of GPS2 regulates cell proliferation and migration through complementary pathways.